The life sciences industry faces rising costs, increased clinical trials, stricter regulations, and supply chain disruptions. To compete, companies must accelerate product innovation, improve speed to patient, enhance product safety, and manage costs. M&A is critical for growth, leading to mega-deals and bolt-on acquisitions.
GEP's life sciences practice partners with leading companies to reduce opex and capex by optimizing manufacturing, R&D, commercialization, procurement, and supply chain performance. Our digital transformation strategists and SMEs identify risks, streamline product innovation, and redesign the supply chain for agility and responsiveness.
Why GEP
Our Approach
GEP understands the hurdles that leadership teams face in the life sciences industry. We offer the right combination of analytical rigor, software solutions, solid execution skills and the experience needed to drive measurable value from supply chain and procurement. Whether it is accurately identifying potential benefits, realizing quick cash flow savings or integrating disparate procurement entities for higher performance, GEP brings proven end-to-end capabilities to every engagement.
We help clients proactively identify third-party risks and manage them more effectively by developing comprehensive supply risk management strategies to mitigate vulnerability and ensure continuity. Our strategic cost management programs across direct materials, SG&A and R&D help identify and eliminate significant expenses to free up cash that can be invested to drive growth and enhance shareholder ROI.
Our Solutions
GEP’s supply chain and procurement solution offerings for pharmaceutical, life sciences and health care enterprises include:
Supply Chain
- Digital supply chain transformation
- Supply risk management for complex and geographically diverse supply chains
- Purchase order collaboration
- Forecast collaboration
- Capacity collaboration
- Quality management
- Inventory management
Procurement
- Digital procurement transformation
- M&A services, including M&A clean-room services, post-merger integration and synergy cost-reduction programs
- Strategic cost management, category strategy development
- Managed procurement services: source-to-contract (S2C) and procure-to-pay (P2P)
- R&D
- Pharma/commercial distribution
- Patient access
Fit-to-purpose engagement models featuring unified end-to-end procurement solutions or custom, flexible options
Our Track Record
Our complete and unified supply chain and procurement solutions focus on strategy, software and managed services to help companies go “beyond the pill” and build fully integrated organizations.
With a perfect combination of onsite/offsite resources for maximum impact, GEP has transformed supply chain and procurement organizations in leading life sciences companies and helped deliver improved patient outcomes and significant competitive advantage.
We have:
- Managed more than $40 billion in spend for more than 50 life sciences clients.
- Helped more than 40 life sciences clients adopt best practices developed through our hundreds of complex engagements with market-leading enterprises and our deep understanding of industry, global and regional regulatory frameworks.
- Seamlessly integrated the procurement functions of leading companies and helped them realize savings.
- Developed robust integration and detailed savings-realization plans through our pre-merger diagnostic services and delivered multiple M&A integration and cost-synergy programs.
- Developed risk mitigation strategies for leading life sciences companies that prioritized risk evaluation in the supplier selection process, categorized contingency plans and built closer collaboration between legal and compliance teams.
GEP Achieves Results
14%
Savings achieved with contracted suppliers for a Fortune 500 life sciences giant
360⁰
Transformation of clinical trials through artificial intelligence and machine learning for a pharma major
40%
Reduction in inventory and improved supply chain collaboration for global pharma company
Industry Insights
GEP Spend Category Outlook Report 2025
GEP Outlook 2023 Life Sciences
How GEP Helped A Pharma Giant Transform R & ED Procurement Infrastructure and Reduce Drug...
The Path to Supplier Diversity: A 6-Step Plan for Life Sciences Companies
How GEP Helped a Global Pharma Giant Drive Synergies Through Post-Merger Clinical Data Ecosystem...
The GEP team enabled us to weather the COVID-19 crisis, and despite all obstacles, helped us transform Bayer’s procurement at full speed. At a time when we needed GEP the most, its partnership and dedication were invaluable in supporting our fight against the coronavirus pandemic and in pursuing the Bayer vision of ‘Health for All, Hunger for None.
Thomas Udesen
Chief Procurement Officer, Bayer
